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Rheumatoid arthritis (RA) is traditionally regarded as an 
archetypal disease of the synovial tissue. Th e synovial 
membrane indeed undergoes early inﬂ ammatory changes, 
which include increased vascularity as well as intimal 
lining layer hyperplasia and accumulation of macro-
phages, plasma cells, T cells, B cells, dendritic cells, 
natural killer cells and mast cells in the sublining, among 
other changes [1]. Collectively, localization of inﬂ amma-
tion to the synovium is primarily responsible for the 
dysregulated cellular and molecular mechanisms that 
ultimately lead to the typical signs and symptoms of RA, 
including joint pain, stiﬀ ness, swelling and structural 
changes. Although the pathogenic and clinical impor-
tance of synovitis is beyond question, it is becoming 
increasingly apparent that a ‘synovio-centric’ model of 
RA could be limiting. Indeed, other anatomic compart-
ments appear to be involved at all stages of the disease. 
Th e most important example comes from the recognition 
that clinical arthritis and subclinical synovitis are antici-
pated by a pre-articular immunologic phase possibly 
developing in lymphoid tissues as well as in the lungs 
[2,3]. Full-blown joint disease itself spreads well beyond 
synovial tissue inﬂ ammation. Established arthritis can be 
characterized by the involvement of at least two other 
compartments that are in direct contact with the joint 
space. Th ese include the draining lymph nodes (LNs) 
[4,5] and, of special relevance, the subchondral bone 
marrow (BM) [6].
As dysregulated B cell responses are central pathogenic 
events in RA and B-cell autoreactivity originates, at least 
in part, from defective checkpoints within the BM (a 
primary lymphoid organ) [7], the role of this compart-
ment in the immunopathogenesis of RA has attracted 
great attention over the years. Data supporting the 
existence of BM abnormalities were mainly derived from 
studies on marrow aspirates/biopsies from the sternum 
and the iliac crest, which are primary hematopoietic and 
immunologic sites in adult life. Th e role that the ‘red 
marrow’ might play in the immunologic disturbances of 
RA thus appears interesting but not completely un-
expected. Less predictably, evidence has accumulated 
supporting the additional involvement of the BM 
adjacent to inﬂ amed joints at peripheral sites. Th is is 
normally a fat-rich tissue (‘yellow marrow’) where 
hematopoiesis is not prominent. In RA, the fat can be 
replaced by a vascularized, cell-rich inﬂ ammatory tissue. 
Combined with imaging data coming from magnetic 
resonance imaging (MRI) studies, histopathologic changes 
described within the subchondral BM have been postu-
lated to be intimately involved in the pathological 
processes producing local inﬂ ammation and tissue 
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remodeling in RA joints [6,8-10]. Here we will discuss the 
most relevant ﬁ ndings related to BM alterations in RA, 
focusing on their morphological characteristics and 
patho logic signiﬁ cance. In view of the clinical relevance 
of MRI ﬁ ndings, special emphasis is given to the 
subchondral BM.
Histopathology of the bone marrow in rheumatoid 
arthritis
Systemic bone marrow
Alongside its hematopoietic function and its role in the 
early selection of lymphocytes, the BM is an immune 
regulatory organ involved in migration, selective retain-
ment and function of innate and adaptive immune cells 
[11]. A variety of morphological, immunophenotypic and 
functional abnormalities in BM cells in RA have been 
detected as a consequence of augmented local production 
of inﬂ ammatory cytokines and cell-cell interactions. Both 
myeloid and lymphoid lineage cells appear aﬀ ected at 
some stage of the disease.
Th e absolute number of mononuclear cells was found 
markedly increased in iliac BM aspirates in RA patients 
compared to controls [12]. In addition, the spontaneous 
generation of CD14+ myeloid cells from BM progenitors 
in vitro as well as their maturation towards HLA-DR+ 
cells were accelerated in RA patients, indicating that 
alterations in the regenerative potential of the BM may 
occur [13,14]. Th e ﬁ nding that levels of IL-6 and IL-8 
were markedly elevated in BM aspirates from RA patients 
(compared with controls) [15] is suggestive of ongoing 
pathology in the BM region. DNA microarray analysis 
also demonstrated that BM cells from RA patients have 
abnormal functional networks in immune response and 
cell cycle when compared to those from osteoarthritis 
patients, with overexpression of genes that take part in 
the antigen presentation pathway and interferon signal-
ing [16]. Studies in experimental arthritis have conﬁ rmed 
a generalized pattern of red marrow conversion with 
enhanced myelopoiesis in conjunction with either 
increased IL-1 and IL-6 activity [17] or TNF overexpres-
sion [18]. Interestingly, high cellularity throughout the 
marrow seen on histologic examination in TNF-trans-
genic mice appears associated with a diﬀ use bone 
marrow edema (BME) pattern on MRI, distinct from 
sub chondral BME coexisting with focal erosions [18]. 
Together with the observed alterations in the myeloid 
compartment, there is evidence that the BM environment 
in patients with RA may harbor aberrant B- and T-cell 
immune responses. Marrow plasmacytosis and hyper-
globulinemia were already described in the 1950s in a 
number of independent studies (reviewed by Duthie and 
colleagues [19]). B cells derived from RA BM were later 
found to be capable of producing RA-associated auto-
antibodies, such as all rheumatoid factor (RF) isotypes 
[20] as well as IgM anti-citrullinated peptide antibodies 
(ACPAs) [21]. Supporting a pathogenic role of T cells in 
this disease, an abnormal accumulation of HLA-DR+CD8+ 
and recently activated CD3+CD4+ T lymphocytes has 
been detected in the iliac BM of RA patients (a site 
remote from inﬂ amed joints) and also in femoral heads 
[12,22,23].
From a morphological perspective, it is worth noting 
that, in chronic inﬂ ammatory conditions such as RA, the 
expanded lymphoid component of the BM may form 
follicle-like structures and undergo a localized process of 
ectopic lymphoid neogenesis. In a series of 65 marrow 
trephines, Engels and colleagues [24] reported morpho-
logically benign lymphoid aggregates in 15 cases, 5 of 
which were diagnosed with RA or other autoimmune 
disorders. More recently, Kuca-Warnawin and colleagues 
[23] conﬁ rmed a follicular pattern of inﬁ ltrating lympho-
cytes in 9 of 15 BM trephine biopsy specimens from RA 
patients. Of these, ﬁ ve exhibited features of compart-
mentalized lymphoid follicles, with a core of CD20+ 
B  cells surrounded by CD4+ T cells and histologic 
evidence of germinal center (GC)-like structures. 
Function ality has yet to be demonstrated at these sites, 
but B-cell clonality was recognized in 9 of 15 patients (4 
with an autoimmune disorder) in the series described by 
Engels and colleagues [24]. Local expression of the 
activation marker CD69 on follicular cells as well as 
increased levels of the T-cell growth factor IL-15 [23] are 
further clues that local immune cell activation may take 
place.
Collectively, the above-mentioned studies suggest that 
the systemic BM compartment may be involved in the 
pathogenesis of RA, though currently available data on 
its morphological alterations and functional properties 
have yet to be integrated into a coherent model of 
disease. Interest in the BM compartment as a potential 
source of biomarkers and information on drug mode of 
action has, however, been renewed following the 
successful introduction of B-cell-targeted therapies in 
RA. Compared to the almost complete suppression of B 
cells in circulation, relatively high numbers of B cells and 
B-cell precursors persist in the BM after rituximab 
treatment [25-28]. Th e remaining B cells mostly consist 
of memory B cells [27]. Patients exhibiting a less complete 
B-cell depletion and high proportion of more mature B 
cell precursors in their BM after rituximab therapy show 
a clinical response of relatively short duration [25]. 
Clinical response has also been shown to be preceded by 
a decrease in the number of memory B cells in the BM 
[28]. Disease relapse after rituximab could thus be 
attributable to several mechanisms related to BM partial 
depletion, involving B cell subsets at diﬀ erent stages of 
diﬀ erentiation and activation. Incomplete suppression of 
B cells in the BM may be due to pharmacokinetic factors, 
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local expression of anti-apoptotic molecules, patient-
related diﬀ erences, or others. Further investigations on 
the mode of action of rituximab in the BM and in other 
compartments of the immune system are awaited in 
order to gain better understanding of the pathogenetic 
and clinical variability of RA.
Subchondral bone marrow
Inﬂ ammatory changes occurring within the juxta-articular 
BM in RA were reported over three decades ago. Barrie 
[29] observed cartilage damage, reparative changes and 
ﬁ brovascular tissue within the subchondral marrow of 
surgically removed metatarsal and metacarpal heads in 
advanced RA. In similar surgical material, Wyllie [30] 
further described proliferation of ﬁ broblasts, deposition 
of collagen, formation of thin-walled vascular channels, 
inﬁ ltrates of macrophages, lymphocytes and plasma cells. 
In RA knee joints, Bromley and colleagues [31] observed 
the presence of blood vessels and inﬂ ammatory cell 
inﬁ ltrates including mononuclear/macrophage cells in 
subchondral regions remote from the synovial pannus-
cartilage junction. Th ese cellular aggregates were adjacent 
to erosions of the articular cartilage. In a similar study of 
RA subchondral bone removed from a patient under-
going knee replacement surgery, Watson and colleagues 
[32] described a local inﬂ ammatory reaction with nodular 
lymphocytic inﬁ ltrates accompanied by immuno globulin 
deposits near areas of destroyed cartilage. More recently, 
in a series of 164 hip arthroplasties performed for various 
joint diseases, O’Connell and colleagues [33] found a 
total of ten cases (six with RA) with subchondral inﬂ am-
mation variably characterized by diﬀ use and nodular 
distribution. Altogether, descriptions of a subchondral 
inﬂ ammatory reaction in damaged RA joints gave rise at 
the end of the 1980s to the hypothesis of a ‘bi-compart-
mental’ model of RA, in which inﬂ ammation of the BM 
of aﬀ ected joints actively contributed to the establish-
ment of local damage [8,31].
Th e almost complete inaccessibility of the BM com part-
ment to either clinical examination or traditional imaging 
(radiography) has contributed to a lack of interest in local 
marrow pathology until recent years. It has only been 
since the advent of MRI that the subchondral bone has 
gained recognition as a site of pivotal importance when 
considering the nature of the inﬂ ammatory process in 
RA. MRI-based BM involvement in the form of BME is a 
common feature in late and early RA, where it associates 
with disease activity and, most importantly, with future 
development of bone erosions and poor functional out-
comes (for a review on BME in RA, see [9,10] and the 
manuscript by FM McQueen in this edition of Arthritis 
Research and Th erapy).
While the clinical importance of MRI-based BM 
involvement has been demonstrated consistently, its 
exact nature and pathologic signiﬁ cance remain largely 
obscure. Whilst the synovial membrane is accessible 
using minimally invasive techniques, which can be 
applied even in the earliest phases of the disease [34], 
histologic veriﬁ cation of the bone edema seen on MRI is 
virtually impossible in early disease because of diﬃ  culties 
in obtaining appropriate biopsy tissue. Th e few published 
studies comparing the histopathology of subchondral 
bone with MRI appearances include patients with long-
standing disease undergoing major joint surgery, in 
which erosive and secondary degenerative changes could 
complicate the picture. Taking into account these limita-
tions, Jimenez-Boj and colleagues [35] in 2007 signiﬁ -
cantly contributed to this ﬁ eld of research by providing 
the ﬁ rst description of the histologic correlates of BME. 
Th e authors had the chance to examine 12 small joints of 
the hand obtained from 3 RA patients scheduled for joint 
replacement surgery and undergoing MRI on the day 
before surgery. Disease duration was 8, 14 and 24 years, 
respectively. Despite the limited number of patients, it 
was consistently shown that BME corresponded to 
regions in which the BM fat had been replaced by an 
inﬂ ammatory inﬁ ltrate rather than true edema. Such 
inﬁ ltrate was dense and highly vascularized in superﬁ cial 
regions of the marrow adjacent to synovial penetration 
through cortical bone (bone erosions), whilst was milder 
(<50% inﬁ ltrates/tissue area) in more central areas. In the 
same year, McQueen and colleagues [36] independently 
conﬁ rmed the presence of osteitis in seven bone 
specimens with BME at MRI obtained from four diﬀ erent 
patients with longstanding disease. On immunohisto-
chemical evaluation of these plus additional bone 
samples (n = 28) from 11 RA patients, the same authors 
later showed that marrow inﬂ ammatory lesions corres-
ponding to BME were characterized by a variable propor-
tion of macrophages, plasma cells, CD8+ T cells and B 
cells [37]. Th e nature and cellular composition of BM 
involve ment in RA has been deﬁ ned in detail by two 
further independent studies using modern immunohisto-
chemical techniques [38,39]. Although direct comparison 
with MRI images was not available, our group could 
demonstrate that the marrow inﬂ ammatory inﬁ ltrate in 
both large and small joints of patients with long-standing 
RA was mainly organized into follicles of B and T 
lymphocytes (Figure  1) [38]. Th ese structures, which 
were highly variable in size and density distribution 
among diﬀ erent bone samples, had acquired, in a propor-
tion of cases, lymphoid-like morphological features, in-
clud ing a peripheral LN addressin-positive vascular 
appa ratus, CD21+ follicular dendritic cell (FDC) net-
works and expression of the lymphoid chemokines 
CXCL13 and CCL21 [38]. Jimenez-Boj and colleagues 
[39] described a similar pattern, with preponderance of B 
cells within marrow aggregates. A more detailed analysis 
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of B-cell markers revealed an abundance of CD27+ 
mature B cells. Plasma cells located at the periphery of 
marrow aggregates contributed 8 ± 4% of total cells [39]. 
A follicular organization of the lymphocytic inﬁ ltrate 
with histologic evidence of GC-like structures has been 
recently conﬁ rmed in three out of six subchondral bone 
specimens obtained from hip replacement surgery in 
patients with advanced RA [23].
Although no direct comparison is available with the 
histologic pattern of BME in other joint diseases, some 
morphological peculiarities of RA osteitis could reﬂ ect 
disease-speciﬁ c mechanisms. BME in the spondylo-
arthritides equally corresponds to a mononuclear inﬁ l-
trate possibly organized into follicles. Here, however, 
T cells largely predominate [40-43], in keeping with the 
limited role attributable to B cells in these conditions 
[44]. On the other hand, the marrow inﬂ ammatory tissue 
in osteoarthritis is mainly ﬁ brovascular with scarce 
cellular inﬁ ltration [45-48]. Th is pattern could result 
from biomechanical (excessive loading) rather than 
inﬂ ammatory alterations [49].
In summary, notwithstanding the relatively small case 
series analyzed and the unavailability of data on early 
arthritis, it appears indisputable that the subchondral 
aspect of the RA joint may harbor regions of bone inﬂ am-
mation (osteitis) dominated by lymphocytes. Whether 
this process is quantitatively or qualitatively comparable 
to synovial inﬂ ammation (synovitis) and to what extent it 
aﬀ ects speciﬁ c disease outcomes will be discussed in the 
next two paragraphs. Table  1 summarizes the main 
ﬁ ndings of modern studies addressing the histologic 
picture of subchondral BM involvement in RA.
Relationship between subchondral bone marrow 
infl ammation and synovitis
Morphological relationship
A detailed description of the histopathology of the 
inﬂ amed synovium in RA goes beyond the scope of this 
review. Some speciﬁ c aspects of the lymphoid inﬂ am ma-
tory inﬁ ltrate, however, deserve brief discussion in light 
of the similarities to BM features.
It has long been recognized that lymphocytes inﬁ l-
trating the inﬂ amed synovium may become organized 
into follicular clusters in a variable but yet considerable 
proportion of tissue specimens [4,50,51]. Although these 
structures frequently lack complex organizational 
features [52], some may acquire speciﬁ c lymphoid-like 
aspects. Th ese include the formation of high endothelial 
venules, the enrichment of T and B cells in partially 
separated areas, the diﬀ erentiation of local stromal cells 
with development of FDC networks and vestiges of the 
ﬁ broblastic reticular network, and the local synthesis of 
homeostatic chemokines [4,52,53]. Whether these struc-
tures may promote local immunological activity and to 
what extent they contribute to RA pathology are critical 
issues. Th e ﬁ ndings of Schröder and colleagues [54] are 
pertinent with respect to this. After microdissection of 
B  lymphocytes from FDC-rich lymphoid aggregates 
within RA synovial membrane, they performed mole cu-
lar analysis of the V-gene repertoire. Th ey found evidence 
Figure 1. Subchondral bone marrow lymphocytic follicles in rheumatoid arthritis. A representative example of the infl ammatory infi ltrate 
in the subchondral bone marrow of a patient with rheumatoid arthritis undergoing joint replacement surgery of the hip. (A) Hematoxylin and 
eosin-stained section showing a mononuclear cell aggregate in the subchondral bone marrow adjacent to synovial tissue invasion into the marrow 
cavity through established cortical erosions. Note that the synovial tissue at the synovium-marrow boundary is mainly fi brous and acellular, whilst 
dense cellular infi ltration can be observed within the marrow space. st, synovial tissue; e, erosion; b, bone; m, marrow. (B,C) Serial histologic sections 
of a mononuclear cell aggregate in the subchondral bone marrow stained for the B-cell marker CD20 (B) and the T-cell marker CD3 (C). Note the 
abundance of CD20 expression in the subchondral bone marrow aggregate. (A) Original magnifi cation ×10; (B,C) original magnifi cation ×40.
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for an oligoclonal repertoire with highly mutated V 
regions, compatible with a local antigen-driven GC-like 
reaction [54]. Furthermore, a large amount of plasma 
cells inﬁ ltrating the synovial tissue appeared to be 
generated by locally activated B cells [55]. Th ese ﬁ ndings 
are consistent with the observed local expression of AID 
(activation-induced cytidine deaminase), an enzyme 
critically involved in somatic hypermutation and class-
switching of the immunoglobulin genes within conven-
tional GCs of secondary lymphoid tissues [56]. Synovial 
lymphoid follicles may represent an histologic feature 
associated with disease severity and target organ damage 
[57]. Ectopic lymphoid aggregates are indeed associated 
with more severe synovial and systemic inﬂ ammation 
[58,59] and B-cell-rich inﬁ ltrates appear a marker of 
erosive disease [60-62]. Whether these relationships are 
linked causally or represent bystander events remains 
unknown. Supporting a direct link between B-cell 
autoimmunity and tissue damage, human autoantibodies 
against citrullinated vimentin have been recently shown 
to induce osteoclastogenesis and bone loss [63].
Although studies directly comparing marrow and 
synovial follicles are limited [39], data presented herein 
indicate that the overall morphological picture mainly 
coincides. Slight diﬀ erences in cellular composition may 
be related to higher proportions of B cells and plasma 
cells and less macrophages in subchondral BM aggregates 
[39]. Consistent with the considerable heterogeneity 
observed at the synovial tissue level [52], characteristics 
of the lymphoid-like features may vary considerably 
among diﬀ erent BM samples. Th us, subchondral BM 
CD21+ FDC networks and histological features of GC-
like structures have been described but appear rare 
[23,32,38] or even absent [39]. Similarly, vascular addres-
sins are found in a variable proportion of specimens 
[38,39]. Other relevant aspects, such as the local organi-
zation of T-cell area ﬁ broblastic reticular networks, have 
been assessed at the synovial tissue level [64] but their 
eventual correlates within the BM are so far unknown. 
Functionality at these sites has yet to be demonstrated. 
Th e possibility of a link between subchondral BM follicles 
and the pathological processes of the disease is suggested 
by the ﬁ nding that these structures are more prominent 
in patients with large numbers of swollen joints, a high 
acute phase response and high titers of RF [39]. 
Histologically, enrichment in marrow follicles has been 
consistently observed in areas of cortical bone 
destruction [38,39,57].
Hierarchical relationship
A critical aspect for our understanding of the actual 
signi ﬁ cance of marrow pathology in RA is the identi-
ﬁ cation of the hierarchical relationship between synovitis 
and subchondral osteitis. Two separate scenarios can 
theoretically be hypothesized: one is that RA is a disease 
starting in the synovial tissue, which then invades the 
subchondral bone cavity through established bone 
erosions; the other is that of a primary BM disease, which 
then spreads to the synovial membrane. In the absence of 
histopathologic data in the very early and possibly pre-
clinical phases of the disease, both theories are based on 
assumptions rather than facts.
Analyses of tissue samples obtained from patients with 
long-standing erosive RA have consistently shown that 
marrow follicles are preferentially located in superﬁ cial 
areas of the subchondral bone at sites of synovial tissue 
penetration through cortical bone erosions (Figure  1A) 
[38,39]. Such a picture appears strongly evocative of an 
‘outside-in’ model in which marrow inﬂ ammation origi-
nates from propagation of adjacent synovial 
Table 1. Main studies addressing the histopathologic picture of subchondral bone marrow involvement in rheumatoid 
arthritis
 Number Disease   
 of samples duration* Site of surgery MRI Main fi ndings
Jimenez-Boj et al. [39] 12 (12 pts) 18.9 (± 2.8) 10 small joints, 1 wrist,  - Lymphocytic aggregates with predominance
   1 large joint  of B cells (immunohistochemistry)
Bugatti et al. [38] 8 (8 pts) 12.5 (± 8.8) 2 small joints, 1 wrist,  - Lymphocytic aggregates (immunohistochemistry)
   5 large joints  
Kuca-Warnawin et al. [23] 6 (6 pts) - 6 large joints - Lymphocytic aggregates (immunohistochemistry)
Jimenez-Boj et al. [35] 12 (3 pts) 15.3 (± 8.1) 12 small joints Available Infi ltration of hematopoietic cells, lymphocytic 
     aggregates, blood vessels (histology)
McQueen et al. [36] 7 (4 pts) 27 (± 11.7) 7 small joints Available Lymphoplasmacytic infi ltration, focal necrosis, 
     fi brosis (histology)
Dalbeth et al. [37] 28 (11 pts) 21 (± 9.6) 23 small joints, 2 wrists,  Available Infi ltration of macrophages, plasma cells, 
   3 ankles  CD8+ T cells, B cells (immunohistochemistry)
Total 73 (44 pts)   54 small joints (hands/feet), 
   7 wrists/ankles, 12 large 
   joints (knee/hip)  
*Data given as mean (± SD) years. Pts, patients.
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inﬂ amma tion. On the other hand, although no clues at 
present indicate that early osteitis morphologically 
corresponds to the osteitis of advanced disease, MRI 
studies in the earliest stages of RA reveal BM alterations 
before any obvious communication with the synovium is 
detectable [65]. Extensive BME has been also documented 
in patients with undiﬀ erentiated arthritis later developing 
RA [66] as well as in patients with ACPA-positive 
palindromic rheumatism, a proposed model of pre-
clinical RA [67]. Histologically, mild inﬂ ammatory 
inﬁ ltrates have been described also in deeper areas of the 
subchondral bone remote from the synovial-marrow 
junction [38,39]. More intriguingly, lymphoid reactions 
occurring at the synovial-marrow boundary are 
conspicuous whilst the corresponding synovial tissue 
penetrating through cor tical erosions is mainly ﬁ brous 
[38]. Altogether, these data would suggest the autonomy 
(at least in part) of osteitis from synovitis. Th e picture is, 
however, further complicated by recent evidence 
demonstrating that the synovium and the BM can 
physiologically communicate through microscopic bone 
canals (<0.5  mm in width or depth) visible using high-
resolution computed tomo graphy [68]. Th ese canals 
could allow the transduction of inﬂ ammation from the 
outside (synovium) to the inside (BM) and vice versa. 
Both routes are theoretically viable. In collagen-induced 
arthritis, mesenchymal cells ori ginat ing from the juxta-
articular BM have been shown to travel to the synovium 
through enlarged bone canals in the pre-arthritic phase 
[69]. On the other hand, in the same experimental model, 
expression of inﬂ ammatory cytokines and 
osteoclastogenic factors has been almost exclusively 
detected at the synovial tissue level, suggesting that 
subchondral BM reactions are in fact driven by signals 
propagating from the synovium [70]. Exactly how the 
ﬁ ndings obtained in animal models ﬁ t into the spectrum 
of human RA awaits further deﬁ nition.
Th e ‘inside-out’ concept may be more applicable in 
other forms of arthritis, such as the spondyloarthritides. 
In anterior spondylitis, inﬂ ammation dominates the BM 
in areas with no adjacent synovium [41,42]. In contrast, 
the centrality of synovitis in RA remains incontestable. 
Imaging and histologic studies have, however, added 
another layer of complexity to models of pathogenesis in 
the inﬂ ammatory arthritides, by demonstrating that joint 
inﬂ ammation is not exclusive to the synovial membrane 
but also extends to the neighboring BM.
Are additional structures involved in the local 
infl ammatory process of RA? The possible contribution of 
the draining lymph nodes
As long as our perspective on joint inﬂ ammation in RA 
has expanded from the synovial compartment to the 
subchondral BM, the draining LN has emerged as an 
additional player involved in multiple aspects of the 
disease. Th ese include the generation of local immuno-
logical responses as well as the control of cell eﬄ  ux from 
the joint.
LN involvement in experimental models appears early 
and possibly antedates clinical arthritis. An increase in 
the percentage of B lymphocytes as well as a high pro-
liferation of CD8+ cells were observed in regional LNs in 
the latency period of adjuvant arthritis [71]. In the K/
BxN model of spontaneous autoimmunity, the LNs drain-
ing the distal joints were found to be essential for the 
ampliﬁ cation of the arthritogenic B-cell response [72]. 
Similarly, changes in the popliteal LN have been reported 
prior to disease onset in TNF-transgenic mice [73,74], 
with accumulation of CD23+CD21highCD1high B cells 
[75-77]. Such a cell population was recently shown to 
diﬀ erentiate locally, to display an enhanced ability to 
capture and process antigens and to exhibit a GC pheno-
type during T-cell-dependent immune responses [78]. 
Th e speciﬁ c relevance of these ﬁ ndings to autoimmune 
responses in RA is currently unknown. Also, early LN 
involvement in humans remains to be demonstrated. 
Former histologic studies on LN biopsies from diﬀ erent 
anatomic sites in established RA described follicular 
hyperplasia and interfollicular plasmacytosis [79] as well 
as increased GCs with high B-cell activity [80]. In RF 
and/or ACPA-positive individuals at risk of developing 
RA and in early arthritis patients, an increase of activated 
CD69+ cells and a signiﬁ cant change in the CD4/CD8 
distribution was reported in inguinal LNs [81]. 
Ultrasound-guided biopsy of inguinal LNs appears 
feasible and safe [82] and promises to yield important 
information in the near future.
Alongside their potential role in modulating auto-
immunity, the draining LNs may be also critically asso-
ciated with the severity of joint involvement. Longitudinal 
studies in TNF-transgenic mice demonstrated a negative 
correlation between LN contrast enhancement and LN 
volume on MRI and local progression of synovitis, 
suggest ing that reduced LN drainage capacity may deter-
mine worst arthritis outcomes [73,74]. A similar relation-
ship between local disease activity in the joints and ultra-
sonographic signs of axillary LN involvement has been 
recently reported in humans [5]. Histologically, arthritic 
ﬂ ares in experimental models are associated with 
ipsilateral LN collapse due to lymphatic obstruction and 
diminished lymphatic ﬂ ow [77]. Accordingly, inhibition 
of lymphatic drainage increases the severity of joint 
inﬂ ammation in TNF-transgenic mice [75].
Relationship between subchondral bone marrow 
infl ammation and bone remodeling
Clinically, BME on MRI is one of the strongest predictors 
of bone erosions in RA [9,10,65]. However, whether such 
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an association implies a causative link remains to be 
determined.
Chondroclasts and osteoclasts were morphologically 
described in the subchondral bone of RA knee joints over 
30 years ago [83]. More recently, using speciﬁ c immuno-
staining we demonstrated tartrate-resistant acid phos-
pha tase (TRAP)- and cathepsin K-positive multi nucleated 
osteoclasts on the marrow side of RA samples, which 
were associated (in terms of density) with the extent of 
subchondral marrow inﬂ ammation [38]. Others have 
later extended these ﬁ ndings by providing evidence of 
local expression of molecules involved in osteoclasto-
genesis and tissue destruction, such as receptor activator 
of NF-κB ligand (RANKL), cathepsins and metallo-
proteinases [37,84]. Together with MRI studies, these 
data would suggest an active participation of the sub-
chondral compartment to joint remodeling processes. 
RA erosions, however, anatomically and radiologically 
remain ‘outside-in’ processes. Th is pattern could be 
ascribed to diﬀ erences in the local balance of erosive and 
reparative mechanisms between the synovial and the 
subchondral side of RA joints. Whilst bone-resorbing 
osteoclasts can be detected on both sides, bone-forming 
osteoblasts and osteoid deposition are recognized only 
on bone surfaces adjacent to the marrow (Figure  2), as 
suggested by studies in experimental arthritis and human 
RA [38,39,85,86]. Th e role of the BM in RA might thus 
not be entirely negative. Accordingly, it has been recently 
shown that repair of bone erosions in RA patients treated 
with TNF inhibitors, although rare, is based on bone 
apposition at the base of erosion and probably involves 
the BM [87].
Conclusion
RA remains a chronic autoimmune disease mainly in-
volv ing the synovial tissue. However, evidence is mount-
ing that the initiation and perpetuation of inﬂ ammation 
may involve additional anatomic compartments, espe-
cially at certain stages of the disease. Following the 
recognition that RA-speciﬁ c autoantibodies may arise 
years before the onset of clinical disease [88] and that the 
production of autoantibodies may persist despite eﬀ ect-
ive suppression of synovial inﬂ ammation [89], the 
question of the speciﬁ c extra-synovial sites contributing 
to RA immunopathology is attracting increasing atten-
tion. In view of its role in the maintenance of B-cell 
Figure 2. Bone cells in the synovial and subchondral compartment in rheumatoid arthritis. (A) Hematoxylin and eosin-stained section of 
a subchondral bone specimen with histologic evidence of erosions and intra-marrow infl ammation. The diff erent distribution of osteoclasts and 
osteoblasts is shown. Areas with osteoclast accumulation are visible on both the synovial (i) and the subchondral (ii) side of the joint. Osteoblasts 
and bone lining cells are instead located on the endosteal surface (iii). st, synovial tissue; b, bone; m, marrow. (B,C) Immunostainings for the 
osteoclast marker tartrate-resistant acid phosphatase (TRAP) showing TRAP-positive multinucleated osteoclasts resorbing bone from the synovium 
(B) as well as from the subchondral bone (C). (D) Immunostaning for parathytoid hormone receptor (PTH-R) showing PTH-R-positive cuboid 
osteoblasts and bone-lining cells in the subchondral compartment. (A) Original magnifi cation ×10; (B-D) original magnifi cation ×100.
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central tolerance and as a survival niche for long-lived 
plasma cells, the systemic BM is a plausible candidate, 
although its involvement in the very early, pre-clinical 
phases of the disease remains speculative. Fascinating but 
still merely hypothetical is the role of secondary 
lymphoid organs, including LNs. Besides their potential 
role in systemic autoimmunity, the same compartments 
(BM and LNs) could be also involved in local pathology 
at the sites of joint inﬂ ammation. From this perspective, 
the subchondral BM of aﬀ ected joints appears tightly 
linked to the processes of local inﬂ ammation and tissue 
remodeling, as suggested by (many) imaging studies and 
(few) histopathologic data. Analogous evidence is emerg-
ing for the draining LNs, whose drainage capacity 
appears inversely related to local arthritis severity in 
experi mental models.
We have just started unraveling the mystery of a ‘multi-
compartmental’ model of RA, but preliminary results 
encourage further research aimed at identifying novel 
pathogenic and clinical targets of the disease that may go 
beyond the well established synovial tissue immuno-
pathologic environment.
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